HELIGENICS

Heligenics is a life science company that develops a technology showing the genetic mutation impact to transform genetic testing and drug development for major diseases. It measures the significance of mutations in the human genome through a parallel in-vitro process called the GigaAssay, measuring the impact of all potential amino acid substitutions in the functional target protein, doing in a few months what would take many years to do it at all. For cancer diagnostics companies, Heligenics' ... functional data enables improved genetic test interpretation, and for pharmaceutical companies, it empowers the conversion of generic drugs into targeted precision medicines or can rescue a failed drug candidate through the identification of variants for a redesigned genetically-stratified clinical trial. The Las Vegas, Nevada-headquartered company was established by Martin Schiller in 2017.More